(Q38017919)

27 August 2017

Calcium handling in human heart failure--abnormalities and target for therapy (English)

1 reference

27 August 2017

0 references

Hannes Reuter

1

1 reference

27 August 2017

Robert H G Schwinger

series ordinal

2

1 reference

27 August 2017

12 June 2012

1 reference

Wiener Medizinische Wochenschrift

27 August 2017

1 reference

27 August 2017

162

1 reference

27 August 2017

13-14

1 reference

27 August 2017

297-301

1 reference

https://scigraph.springernature.com/pub.10.1007/s10354-012-0117-9

27 August 2017

0 references

cites work

Ca2+-dependent modulation of single human cardiac L-type calcium channels by the calcineurin inhibitor cyclosporine

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

L-type calcium channel auto-regulation of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

SUMO1-dependent modulation of SERCA2a in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

Oral levosimendan in patients with severe chronic heart failure --the PERSIST study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

Adenylyl cyclase type VI corrects cardiac sarcoplasmic reticulum calcium uptake defects in cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-012-0117-9

Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum

21 January 2018

1 reference

12 December 2020

Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation

1 reference

12 December 2020

Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure

1 reference

12 December 2020

The Na+-Ca2+ exchanger is essential for the action of cardiac glycosides

1 reference

12 December 2020

10.1007/S10354-012-0117-9

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1011217928

0 references

Fatcat ID

release_t4ql4ohehzetzozbpnyruk3t5m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t4ql4ohehzetzozbpnyruk3t5m

24 November 2022

mapped directly with Wikidata item

1 reference